COMPLEMENTATION OF A CAPSULE-DEFICIENT MUTATION OF CRYPTOCOCCUS-NEOFORMANS RESTORES ITS VIRULENCE

被引:394
作者
CHANG, YC [1 ]
KWONCHUNG, KJ [1 ]
机构
[1] NIAID, CLIN INVEST LAB, BETHESDA, MD 20892 USA
关键词
D O I
10.1128/MCB.14.7.4912
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Capsule formation plays a significant role in the pathogenicity of Cryptococcus neoformans. To study the molecular basis of capsule synthesis, the capsule-deficient phenotype of a mutant strain was complemented by transformation. A plasmid rescued from the resulting Cap(+) transformant complemented a cap59 mutation which was mapped previously by classical recombination analysis. Gene deletion by homologous integration resulted in an acapsular phenotype, indicating that we have identified the CAP59 gene. The CAP59 gene was assigned to chromosome I by Southern blot analysis of contour-clamped homogeneous electric field gel electrophoresis-resolved chromosomes of C. neoformans var. neoformans. Sequence comparison of genomic and cDNA clones indicated the presence of six introns CAP59 encoded a 1.9-kb transcript and a deduced protein of 458 amino acids. Analysis of the nucleotide sequence revealed little similarity to existing sequences in the data bank. When the capsule-deficient phenotype was complemented, the originally avirulent C. neoformans strain became virulent for mice. In addition, the acapsular strain created by gene deletion of CAP59 lost its virulence. This work demonstrates the molecular basis for capsule-related virulence and that the CAP59 gene is required for capsule formation.
引用
收藏
页码:4912 / 4919
页数:8
相关论文
共 30 条
[1]   STRUCTURE OF THE CAPSULAR POLYSACCHARIDE FROM CRYPTOCOCCUS-NEOFORMANS SEROTYPE-C .2. [J].
BHATTACHARJEE, AK ;
KWONCHUNG, KJ ;
GLAUDEMANS, CPJ .
MOLECULAR IMMUNOLOGY, 1979, 16 (07) :531-532
[2]   CAPSULAR POLYSACCHARIDES FROM A PARENT STRAIN AND FROM A POSSIBLE, MUTANT STRAIN OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A [J].
BHATTACHARJEE, AK ;
KWONCHUNG, KJ ;
GLAUDEMANS, CPJ .
CARBOHYDRATE RESEARCH, 1981, 95 (02) :237-247
[3]  
BHATTACHARJEE AK, 1984, REV INFECT DIS, V6, P619
[4]   THE MAJOR CAPSULAR POLYSACCHARIDE OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-B [J].
BHATTACHARJEE, AK ;
KWONCHUNG, KJ ;
GLAUDEMANS, CPJ .
CARBOHYDRATE RESEARCH, 1992, 233 :271-272
[5]  
CHANG Y, UNPUB
[6]   A GALACTOXYLOMANNAN ANTIGEN OF CRYPTOCOCCUS-NEOFORMANS SEROTYPE-A [J].
CHERNIAK, R ;
REISS, E ;
TURNER, SH .
CARBOHYDRATE RESEARCH, 1982, 103 (02) :239-250
[7]   A COMPREHENSIVE SET OF SEQUENCE-ANALYSIS PROGRAMS FOR THE VAX [J].
DEVEREUX, J ;
HAEBERLI, P ;
SMITHIES, O .
NUCLEIC ACIDS RESEARCH, 1984, 12 (01) :387-395
[8]   PRODUCTION, CHARACTERIZATION, AND ANTIBODY SPECIFICITY OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH CRYPTOCOCCUS-NEOFORMANS CAPSULAR POLYSACCHARIDE [J].
DROMER, F ;
SALAMERO, J ;
CONTREPOIS, A ;
CARBON, C ;
YENI, P .
INFECTION AND IMMUNITY, 1987, 55 (03) :742-748
[9]   SEROTYPING OF CRYPTOCOCCUS-NEOFORMANS BY USING A MONOCLONAL-ANTIBODY SPECIFIC FOR CAPSULAR POLYSACCHARIDE [J].
DROMER, F ;
GUEHO, E ;
RONIN, O ;
DUPONT, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (02) :359-363
[10]   ISOLATION OF TELOMERE-LIKE SEQUENCES FROM CRYPTOCOCCUS-NEOFORMANS AND THEIR USE IN HIGH-EFFICIENCY TRANSFORMATION [J].
EDMAN, JC .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) :2777-2783